CLINICAL CASE
REVISTA DE LA FACULTAD DE MEDICINA HUMANA 2024 - Universidad Ricardo Palma
1 Grupo Investigación de Medicina Crítica y Cuidados Intensivos GIMCCI. Universidad Tecnológica
de Pereira, Pereira, Risaralda, Colombia
ABSTRACT
Background: Ophidic accident is a neglected disease that affects tropical countries. Latin America is
the second region after Africa, with the most cases worldwide. Local lesions accompany its clinical
course up to systemic affectations such as renal, hematological, and neurological lesions. Cardiac
complications are rare, especially in patients who do not have cardiovascular risk factors. There are
reports of acute myocardial infarction, but there is little information about heart failure due to
Bothrops spp.
Case report: We present the case of a 25-year-old man without cardiovascular risk factors who was
admitted to the intensive care unit and developed heart failure with cardiogenic shock and multi-organ
failure secondary to a snake bite.
Conclusions: Although the characteristic clinical course of a bothropic ophidian accident and its
systemic manifestations are mainly related to coagulation abnormalities, there are cardiovascular
complications within its clinical presentation that, although rare, if not detected promptly and not
adequately managed, are associated with high morbidity and mortality.
Keywords: Bothrops spp, cardiogenic shock, Colombia, heart failure, ophidic accident (Source:
MeSH).
RESUMEN
Antecedentes: El accidente ofídico es una enfermedad desatendida que afecta a los países
tropicales. América Latina es la segunda región después de África, con mayor número de casos a nivel
mundial. Su curso clínico incluye lesiones locales hasta afectaciones sistémicas como lesiones renales,
hematológicas y neurológicas. Las complicaciones cardiacas son raras, especialmente en pacientes que no
tienen factores de riesgo cardiovascular. Hay reportes de infarto agudo de miocardio, pero existe poca
información sobre la insuficiencia cardíaca debida a Bothrops spp.
Reporte de caso: Presentamos el caso de un hombre de 25 años sin factores de riesgo
cardiovascular que fue admitido en la unidad de cuidados intensivos y desarrolló insuficiencia cardíaca
con choque cardiogénico y fallo multiorgánico secundario a una mordedura de serpiente.
Conclusiones: Aunque el curso clínico característico de un accidente ofídico bothrópico y sus
manifestaciones sistémicas están principalmente relacionadas con anomalías de la coagulación, hay
complicaciones cardiovasculares dentro de su presentación clínica que, aunque raras, si no se detectan
prontamente y no se manejan adecuadamente, están asociadas con alta morbilidad y mortalidad.
Palabras clave: Bothrops spp, choque cardiogénico, Colombia, insuficiencia cardíaca, accidente
ofídico. (Fuente: MeSH).
INTRODUCTION
The existence of 3000 snake species has been estimated worldwide, of which 600 are poisonous and
threaten public health (1). Therefore, in 2019, the World Health
Organization (WHO) established the
venomous snake bite as a neglected tropical disease (2), with 5.4 million
cases reported each year, 95
000 fatalities, and 300 000 patients with some degree of disability (2). In
Latin America, 70 000 cases
per year are reported. Children, young agricultural workers and people from rural areas are among the
most affected (2 - 4).
Clinical findings range from local alterations such as erythema, pain, and bleeding (5) to systemic
complications like coagulopathies, necrosis, bacterial infections, nephropathies, and unusual
complications like myocardial infarction and arrhythmias (4, 6), reports of more systemic severe
alterations are rare (7). Heart failure secondary to bothropic accident is
infrequent; its origin is
multifactorial due to hypercoagulability, direct cardiotoxicity, vasospasm, hypoperfusion due to
hypovolemic shock and imbalance between procoagulant and anticoagulant elements; these factors can
generate acute myocardial injury with heart failure and cardiogenic shock, events that have a
significant impact on the prognosis of this pathology (16, 17,
18). Therefore, appropriate knowledge of
the treatment of venomous snake bites by medical staff is crucial to improving survival rates from this
condition (8). Consequently, the case of a 25-year-old male, without any
cardiovascular risk factors,
who was admitted to the intensive care unit (ICU) due to acute heart failure after being bitten by a
Bothrops spp snake is presented.
CASE REPORT
A 25-year-old male, afro-descendant, agricultural worker, resident of a rural area, without known past
diseases. He was admitted due to a Bothrops spp snake bite five hours earlier on the middle third of the
posterior region of the right lower limb. Two punctiform lesions with mild but active bleeding were
present. Edema, a diameter difference greater than four cm compared to the left lower limb, absent
distal pulses, and sensitivity alterations were also present. A local expert identified the genus of the
snake.
Laboratory tests showed prolongation of coagulation times (aPTT: 54.8 sec. – Reference Range: 29.2 sec.
PT: 47.7 sec. control: 12.9 sec. INR: 4.00), normal fibrinogen (>1200 mg/dL), creatinine phosphokinase
(CPK) (7261.0 U/L) -elevated. Therefore, according to the National Institute of Health (NIH), the case
was classified as severe, and the patient was treated according to the antivenom recommendations. In
addition, doppler ultrasonography of the right lower extremity arteries and veins was performed, which
showed signs of compartment syndrome (absence of color flows within the posterior tibial artery;
posterior and anterior tibial veins). Therefore, fasciotomy of the lateral and medial compartments of
the leg from knee to ankle was required, and muscle necrosis was observed during the procedure (figure
1).
The patient was transferred to the ICU for postoperative care and required vasoactive support due to
hemodynamic instability. The patient also showed severe and progressive changes in tissue perfusion
parameters (SvcO2: 57 %, delta-pCO 2: 9, lactate: 9.9). An increase in vasoactive support dose and a
second vasoactive drug was necessary. A transthoracic echocardiogram shows dilated cardiomyopathy with
biventricular failure, left ventricular ejection fraction (LVEF): 25 %; a tricuspid annular plane
systolic excursion (TAPSE) of 14 mm was performed. In addition, biomarker elevation (troponin I: 6.00
ng/ml - reference range: 0-0.120 ng/ml) indicated acute myocardial injury. Due to the echocardiographic
findings and clinical condition, inotropic support with dobutamine was implemented. The patient
progressed to acute type 1 respiratory failure, and advanced airway management with invasive mechanical
ventilation was necessary (figure 2).
The patient presented dobutamine intolerance with persistent tachycardia (heart rate > 130 per minute), so a change to levosimendan (dose 0.1 μg/kg/min for 24 hours) was needed. However, hyperlactatemia persisted, and high doses of vasoactive drugs were required. Invasive hemodynamic monitoring via pulmonary artery catheter (PAC) showed a hemodynamic pattern of cardiogenic shock (table 1). The patient progressed to multiple organ dysfunction syndrome by cardiovascular (cardiogenic shock), pulmonary (pulmonary edema), renal (acute kidney injury), hematological (coagulopathy) and liver involvement (transaminase elevation). Due to the extension of muscle necrosis and the loss of limb viability, on the second day of hospitalization, a supracondylar amputation of the right inferior limb was carried out. A second inodilator was required (milrinone dose: 0.1 μg/kg/min). Afterward, the patient tolerated decreased vasoactive support and improved his tissue perfusion and kidney function indicators and reaching hemodynamic stability. On the fourth day of hospitalization, a control transthoracic echocardiogram showed LVEF recovery to 50 %. In the following days, the inodilator decreased, orotracheal extubation was carried out, and the patient was transferred to the general ward on the fifth day of hospitalization.
Hemodynamic variables |
Values |
Hemodynamic variables |
Values |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardiac Index |
2.0 L/min/m2 |
BSA |
2024 m2 |
||||||||||||
SV |
46.5 mL |
SVI |
23.0 ml/m2 |
||||||||||||
SRV |
1259 Dinas/cm5 |
SRVI |
2549 Dinas*m2/cm5 |
||||||||||||
PVR |
120 Dinas/cm5 |
PVRI |
243 Dinas*m2/cm5 |
||||||||||||
LVSW |
48.1 g*m |
LVSWI |
23.8 g*m/m2 |
||||||||||||
RVSW |
12.65 g*m |
RVSWI |
6.25 g*m/m2 |
BSA: body surface area, SV: stroke volume, SVI: systolic volume index, SVR: systemic vascular resistance, SVRI: systemic vascular resistance index, PVR: pulmonary vascular resistance, PVRI: pulmonary vascular resistance index, LVSW: left ventricular systolic work, LVSWI: left ventricular systolic work index, RVSW: Right Ventricular Systolic Work, RVSWI: right ventricular systolic work index.
DISCUSSION
Snakebite poisoning, specifically by the Bothrops snake, can have several pathophysiological effects on
the body, what includes the risk of cardiogenic shock. Bothrops is a genus of venomous snakes found in
Central and South America (2, 3). Here, we describe some of
the basic pathophysiological mechanisms
related to the development of cardiogenic shock after a Bothrops bite:
Hemorrhagic toxins: Bothrops venom contains proteolytic enzymes and metalloproteinases that can
cause damage to blood vessels and surrounding tissues. This vascular damage leads to localized bleeding
and, in severe cases, a hemorrhagic syndrome that can affect multiple organs (4).
Compartment syndrome: Tissue breakdown and localized edema can increase pressure in the affected
muscle compartments. This increase in pressure can compromise local blood flow and contribute to shock
development (5).
Activation of the coagulation system: Bothrops venom can activate the coagulation system, which
can result in a cascade of events leading to the formation of clots and consumption of clotting factors.
This activation may contribute to microvascular thrombosis and tissue damage (6).
Hypotension: Blood loss due to the hemorrhagic action of the venom, and possible decreased
vascular resistance can lead to hypotension, a fundamental component of cardiogenic shock (6).
Myotoxicity: Some Bothrops species can have myotoxic effects, what causes direct damage to muscle
cells. The release of myoglobin and other damaged cellular products can contribute to acute renal
failure, further aggravating the patient's hemodynamic condition (7).
It is important to note that the clinical picture may vary, which dependss on the specific species of
Bothrops and the amount of venom inoculated. Immediate medical attention is crucial in venomous snake
bites to counteract the effects of the venom and prevent serious complications such as cardiogenic
shock. Depending on the patient's clinical manifestations, treatment may include antivenom
administration, hemodynamic support measures, and other specific therapeutic approaches (7, 8).
Venomous snake bite is a neglected tropical disease of great interest in public health (1, 2), and 5.4
million cases are reported yearly. It primarily affects tropical countries as Latin America, the second
most affected territory after Africa (9). Countries like Brazil report the
highest cases, approximately
26 000 ophidian accidents yearly (3). In Colombia, up to 4000 cases have
been reported (10), and it is
the second country in Latin America with the highest number of cases (3, 10). Young men who work as
farmers are the most affected (4, 9, 10),
and Bothrops spp is the most prevalent species and responsible
for 70 to 90 % of cases in the region (10 - 12).
Alterations caused by venomous snake bites are well known; local symptoms such as swelling, pain,
bleeding, edema, and muscle necrosis associated with systemic involvement (hematological and renal
mainly) are common (3, 4, (13)); on the other hand, different studies agree that cardiac
complications are
rare, especially among subjects without cardiovascular risk factors or known cardiac diseases (7). Four
possible mechanisms have been proposed for the development of acute myocardial infarction in both humans
and animals after an ophidian accident that generates heart failure: 1) vasospasm secondary to venom, 2)
coronary thrombosis due to hypercoagulability, 3) direct cardiotoxicity generating myocarditis and 4)
hypovolemic shock due to capillary leakage generation (16, 17). The venom of snakes of the Viperidae
family contains activators of factor V and factor X, which generate changes in the
procoagulant-anticoagulant balance. As a result, there is evidence of thrombosis of the coronary,
cerebral, and pulmonary vasculature (18). Generally, this type of event
does not lead to thrombosis in
humans since, in most cases, the venom injection is subcutaneous or intramuscular, leading to the
development of coagulopathy, preferably by consumption (19, 20), but in the case of this patient, due to
the large size of the snake, the volume of venom injected was very high with high penetration at
intravascular level, what increases the risk of thrombosis.
In this case, it was defined as an acute cardiac injury due to troponin elevation with values greater
than p99, associated with clinical and echocardiographic manifestations of myocardial ischemia, accord
to the fourth definition of myocardial infarction (17). Likewise, heart
failure was documented due to
the rapid progression of symptoms, a LVEF severely reduced, a Stevenson C hemodynamic profile, and signs
of tissue hypoperfusion, what indicates cardiogenic shock confirmed by invasive hemodynamic monitoring
with pulmonary artery catheter (18).
A study, performed in Brazil by Souza et al., identified risk factors for mortality in Brazilian
Amazonia. They found that Bothrops spp caused most cases, and fatal complications were respiratory
failure and kidney injury in 37 and 29.1 % of cases, respectively (12).
Only one patient with cardiac
involvement was identified. These data might be correlated with those obtained by Suresh et al. after
identifying the cause of death in a cohort of 533 patients in South India, where the most prevalent
cause of death was renal failure in 22.9 % of cases, and several cases of death, caused by cardiac
involvement, were reported (14).
Likewise, a study by Sarmiento et al., that comprised 42 patients, showed that the most frequent
complications were hematological and dermatological in 19.02 % of cases. However, it showed that three
patients had cardiac involvement and presents myocardial infarction (15).
Limitations and strengths
The clinical case has several limitations, among which we highlight that heart failure secondary to a
bothropic accident is a rare entity, so the literature available for its specific management is scarce,
without forgetting that patients admitted to the ICU due to a bothropic accident have high mortality; on
the other hand, in our context there is no availability of the adequate number of antidote vials, making
its management more difficult. The main strengths are related to the timely detection, advanced
hemodynamic monitoring, and management of heart failure with secondary cardiogenic shock, as well as the
different complications associated with the multi-organ dysfunction syndrome that the patient presented.
CONCLUSIONS
Although the characteristic clinical course of a bothropic ophidian accident and its systemic
manifestations are mainly related to coagulation abnormalities, there are cardiovascular complications
within its clinical presentation that, although rare, if not detected on time and not properly managed,
are associated with high morbidity and mortality.
Authorship contributions:
Andres Restrepo-Bastidas: Study concept and design, acquisition, analysis, and
interpretation of data, drafting of the manuscript, critical revision of the manuscript for
important intellectual content, original material, and construction of figures.
Mateo Aguirre-Flórez: Study concept and design, acquisition, analysis, and interpretation of
data. English translation.
Jaime Andrés Hoyos-Muñoz: Critical revision of the manuscript for important intellectual
content and study supervision.
Melissa González-Ramírez: Critical revision of the manuscript for important intellectual
content and study supervision.
David Echeverry-Piedrahita: Critical revision of the manuscript for important intellectual
content and study supervision.
Financing:
Self-financed
Declaration of conflict of interest:
None of the authors declare conflicts of interest.
Recevied:
December 4, 2023
Approved:
February 29, 2024
Correspondence author:
Mateo Aguirre Flórez
Address:
Cra. 27 #10-02, Pereira, Risaralda, Colombia
E-mail:
maguirref96@utp.edu.co
Article published by the Journal of the faculty of Human Medicine of the Ricardo Palma University. It is an open access article, distributed under the terms of the Creatvie Commons license: Creative Commons Attribution 4.0 International, CC BY 4.0 (https://creativecommons.org/licenses/by/1.0/), that allows non-commercial use, distribution and reproduction in any medium, provided that the original work is duly cited. For commercial use, please contact revista.medicina@urp.edu.pe.